Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Aug 24, 2010


San Francisco-based molecular diagnostics startup MLC Dx recently disclosed several company executives in an SEC filing.

Thomas Willis is the company’s president and CEO. Prior to that, he worked at Affymetrix, following the firm’s acquisition of ParAllele BioScience, a company he co-founded and where he served as CEO and later as CSO.

Malek Faham is the firm’s CSO. Previously, he was vice president of oncology technology research at Affymetrix, and before that, director of research at ParAllele, which he also co-founded.

Lawrence Tabak has been appointed as principal deputy director of the National Institutes of Health. He succeeds Raynard Kington, who is leaving the NIH to become president of Grinnell College in Iowa.

Tabak has served as director of the National Institute of Dental and Craniofacial Research since 2000. He also served as acting NIH deputy director in 2009 and, most recently, as acting director of the Division of Program Coordination, Planning, and Strategic Initiatives. Previously, he was a professor of dentistry, biochemistry, and biophysics at the School of Medicine and Dentistry at the University of Rochester. He holds a DDS from Columbia University, a PhD and a certificate of proficiency in endodontics from the University of Buffalo, and an undergraduate degree from City College of the City University of New York.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.